← Open Payments lookup

OMAR LONGORIA: Open Payments

NPI 1952061988 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,155 in 55 payments from 13 companies in 2025. Trend: 2023 $597 · 2024 $914 · 2025 $5,155

Consulting: $2,450Food & beverage: $1,597Travel & lodging: $1,108
CompanyPaymentsAmount
Gilead Sciences, Inc.14$4,249
Novo Nordisk Inc17$415
AstraZeneca Pharmaceuticals LP5$99
Astellas Pharma US Inc4$90
ABBVIE INC.5$70
Lilly USA, LLC2$50
Sumitomo Pharma America, Inc.2$40
JAZZ PHARMACEUTICALS INC.1$38
ViiV Healthcare Company1$30
Bioventus LLC1$21

Products named: Yeztugo, Ozempic, AIRSUPRA, Veozah, UBRELVY, JARDIANCE, GEMTESA, EPIDIOLEX.

Industry payments across TX — which companies pay providers there.